🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Timmerman Traverse for Life Science Cares 2023. The team raised $1.23 million to fight poverty. Ready to go hike the Presidential Traverse! Thanks to all the hikers and donors.

Hot on the heels of their Seed announcement, Amber Bio is unveiling Splice Editing – a novel gene editing method leveraging endogenous splicing machinery and newly discovered CRISPR-Cas systems to achieve large edits. Preprint by Jacob Borrajo Basem Al-Shayeb, Ph.D. 🧬 & team👇cc Vineeta Agarwala

Congrats Jacob Borrajo Basem Al-Shayeb, Ph.D. 🧬 and the team at Amber Bio!

Exciting milestone for Thyme Care: Series B to support many more cancer patients in their care journeys. Welcome to new partners Town Hall Ventures and Foresite Capital and congrats to the Thyme Care team!

So happy to be joining as an advisory partner at a16z a16z Bio + Health to help usher in the next-generation of biotechs, therapies, and therapeutic modalities with Jorge Conde Becky Pferdehirt Vineeta Agarwala Vijay Pande Ben Portney Zak Doric, PhD and team!! bio-eats-world.simplecast.com/episodes/partn…

.🧬🚀 Vineeta Agarwala and I couldn't be more excited to have the opportunity to support Mana Bio as they pioneer the field of AI designed LNPs for next generation delivery of genetic medicines. Huge congrats to Mana co-founders Yogev Debbi, Avi Schroeder, Kira Radinsky and Roy Nevo !!

Super thrilled to see @Tome_bio come out of stealth to translate the vision of programmable gene replacement as a new editing modality for genomic medicines and cell therapy. Started this company with Jonathan Gootenberg to solve challenges in the gene therapy and gene editing fields. 🧵👇

I’m really excited to be able to share more about what I’ve been working on for the last couple of years! Couldn’t be more thrilled to be working with Josh Haimson and the rest of this super talented team on the important problem of getting better drugs to the clinic, faster.

I’m excited to start sharing more publicly what I’ve been working on for the last couple of years! At Inductive, we're focused on delivering better therapies to patients, faster, by accelerating compound optimization with fit-for-purpose datasets and ML #ML #AI #DrugDiscovery

World, meet Inductive Bio! An ML-powered platform to learn from large datasets + accelerate small molecule optimization. Co-founded by Josh Haimson + Ben Birnbaum, who previously started and ran the ML team Flatiron Health (where we met). Excited to be working together again!

Quoting my own post again as it is so important. Don’t show more bias and stigma employers by making people jump through hoops to get treatment. Just provide good comprehensive care!

Go Dr Emeline Aviki, MD, MBA!! nyulangone.org/news/perlmutte…

Our goals: New medicines. New practice of medicine. Our team: a16z's global venture capital platform, together with Eli Lilly and Company, the largest pharma company in the world. Go :) Excited about the opportunities ahead! cc Jorge Conde a16z Bio + Health statnews.com/2025/01/10/eli…

I am very excited to be working with the Eli Lilly team on this exciting new fund that will make it easier for founders to succeed in bio tech! Vineeta Agarwala a16z.com/announcement-a…

Welcome Erik Torenberg!!

Drug design today remains a bespoke craft done through years of scientific trial-and-error. In order to develop a single approved therapy, medicinal chemists design and synthesize over 20,000 molecules -- balancing a drug’s potency with its properties of absorption, distribution,